An evaluation of 25B-, 25C-, 25D-, 25H-, 25I-and 25T2-NBOMe via LC-MS-MS: Method validation and analyte stability

Journal of Analytical Toxicology

Volumn 38, Issue 8, 2014, Pages 479-484

  Johnson, Robert D ^a   Botch Jones, Sabra R ^b   Flowers, Tiffany ^a   Lewis, Connie A ^a  

^a Tarrant County Medical Examiner's Office   (United States)

^b FTox Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 IODO 2,5 DIMETHOXYPHENYL) N [(2 METHOXYPHENYL)METHYL]ETHANAMINE; SEROTONIN 2A AGONIST; UNCLASSIFIED DRUG; SEROTONIN 2 AGONIST;

ARTICLE; AUTOPSY; BLOOD ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIMIT OF QUANTITATION; MEASUREMENT ACCURACY; STORAGE TEMPERATURE; TANDEM MASS SPECTROMETRY; THERMOSTABILITY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; BLOOD; CLASSIFICATION; LIQUID CHROMATOGRAPHY; PROCEDURES; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; URINE; VALIDATION STUDY;

CHROMATOGRAPHY, LIQUID; HUMANS; LINEAR MODELS; SENSITIVITY AND SPECIFICITY; SEROTONIN 5-HT2 RECEPTOR AGONISTS; TANDEM MASS SPECTROMETRY;

EID: 84928184656     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bku085     Document Type: Article

References (7)

1. Poklis, J.L., Devers, K.G., Arbefeville, E.F., Pearson, J.M., Houston, E., Poklis, A. (2014) Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Science International, 234, e14-e20.
2. Poklis, J.L., Nanco, C.R., Troendle, M.M., Wolf, C.E., Poklis, A. (2014) Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)-methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Testing and Analysis, 6, 764-769.
3. Rose, S.R., Poklis, J.L., Poklis, A. (2013) A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug. Clinical Toxicology (Philadelphia), 51, 174-177.
4. Poklis, J.L., Charles, J., Wolf, C.E., Poklis, A. (2013) High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum. Biomedical Chromatography, 12, 1794-1800.
5. Casale, J.F., Hays, P.A., Bright, S.J., Barratt, M.J. (2012) Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl) phenethylamine (NBOMe) derivatives and differentiation from their 3-and 4-methoxybenzyl analogues-Part I. Microgram Journal, 9, 85-109.
6. Braden, M.R., Parrish, J.C., Naylor, J.C., Nichols, D.E. (2006) Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Molecular Pharmacology, 70, 1956-1964.
7. Johnson, R.D., Botch-Jones, S.R. (2013) The stability of four designer drugs: MDPV, mephedrone, BZP and TFMPP in three biological matrices under various storage conditions. Journal of Analytical Toxicology, 37, 51-55.